{"id":96052,"date":"2026-04-09T15:55:27","date_gmt":"2026-04-09T12:55:27","guid":{"rendered":"https:\/\/forklog.com\/en\/?p=96052"},"modified":"2026-04-09T16:00:16","modified_gmt":"2026-04-09T13:00:16","slug":"cortecs-stroke-treatment-implant-gains-breakthrough-device-status","status":"publish","type":"post","link":"https:\/\/forklog.com\/en\/cortecs-stroke-treatment-implant-gains-breakthrough-device-status\/","title":{"rendered":"CorTec’s Stroke Treatment Implant Gains ‘Breakthrough Device’ Status"},"content":{"rendered":"

The United States Food and Drug Administration (FDA) has granted<\/a> the ‘breakthrough device’ designation to CorTec’s BCI<\/span> system.<\/p>\n

This designation is awarded to innovative medical solutions for the effective treatment or diagnosis of serious diseases. The FDA program accelerates the development and evaluation of technologies, ensuring patients have quick access to vital therapies without compromising safety standards.<\/p>\n

The status is intended to facilitate the development and assessment of medical devices through priority and more interactive engagement with the FDA. It applies to the use of direct electrical stimulation of the cerebral cortex. The technology aims to restore motor functions in individuals with chronic motor impairments caused by stroke.<\/p>\n

CorTec’s brain-computer interface device combines neural signal recording and adaptive stimulation in a closed-loop system. The platform is undergoing FDA-approved clinical trials at the University of Washington in Seattle.<\/p>\n

\n

\u201cThis is the first clinical analysis of a fully implantable wireless BCI system for stroke rehabilitation in humans,\u201d the announcement stated.<\/p>\n<\/blockquote>\n

Acute cerebrovascular accidents are a leading cause of acquired long-term disability in adults. Annually, approximately 9 million cases of ischemic stroke are recorded worldwide, with about 1.7 million in the US and Europe.<\/p>\n

More than 80% of patients suffer from upper limb dysfunctions, and approximately 50% remain permanently disabled.<\/p>\n

For patients with chronic stroke and moderate to severe motor impairments who have plateaued after traditional therapy, there is currently no approved implantable treatment.<\/p>\n

\n

\u201cToday, only a few BCI companies worldwide, including Neuralink, Synchron, and Blackrock Neurotech, have received the ‘breakthrough device’ status. This step is a significant milestone for CorTec and underscores the potential of our system to meet the substantial need for stroke rehabilitation,\u201d stated the company’s CEO, Frank Dezeure.<\/p>\n<\/blockquote>\n

He added that the system demonstrates signal stability for 500 days.<\/p>\n

Several BCI technologies from other companies offer the ability to communicate by controlling digital devices with thought. CorTec is developing a bidirectional solution with therapeutic neurostimulation for physical rehabilitation.<\/p>\n

This is a unique development with ‘breakthrough device’ status, the company emphasized.<\/p>\n

In addition to stroke recovery, the platform is being tested for epilepsy treatment. Work is also underway to expand the range of indications, including assistance with paralysis and depression.<\/p>\n

Previously, BCI user Galen Buckwalter learned to create music<\/a> with the power of thought.<\/p>\n","protected":false},"excerpt":{"rendered":"

The United States Food and Drug Administration (FDA) has granted the ‘breakthrough device’ designation to CorTec’s BCI system.<\/p>\n","protected":false},"author":1,"featured_media":96053,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"select":"1","news_style_id":"1","cryptorium_level":"","_short_excerpt_text":"FDA grants 'breakthrough device' status to CorTec's BCI system for stroke rehabilitation.","creation_source":"","_metatest_mainpost_news_update":false,"footnotes":""},"categories":[3],"tags":[438,1812],"class_list":["post-96052","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-and-analysis","tag-artificial-intelligence","tag-brain-computer-interface-bci"],"aioseo_notices":[],"amp_enabled":true,"views":"11","promo_type":"1","layout_type":"1","short_excerpt":"FDA grants 'breakthrough device' status to CorTec's BCI system for stroke rehabilitation.","is_update":"","_links":{"self":[{"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/posts\/96052","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/comments?post=96052"}],"version-history":[{"count":1,"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/posts\/96052\/revisions"}],"predecessor-version":[{"id":96054,"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/posts\/96052\/revisions\/96054"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/media\/96053"}],"wp:attachment":[{"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/media?parent=96052"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/categories?post=96052"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/forklog.com\/en\/wp-json\/wp\/v2\/tags?post=96052"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}